ADSS2 and myopathy: Ironically, using modern “big data” omics techniques, adenylosuccinate synthetase (ADSS) expression has recently been shown to be as significantly downregulated in DMD muscle as in the primary ADSS-deficient disease, ADSSL1 myopathy [9].